Back to Market Feed

APRISO ER 0.375 GRAM CAPSULE

$4.0710per EA

Strength

375 mg/1

Manufacturer

Salix Pharmaceuticals Inc.

NDC

65649010302

Classification

Brand

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Last Updated

9/17/2025

Active Ingredients

Approval Type

New Drug (NDA)

FDA Application

On Market Since

10/31/2008

Pharmacological Classes

Aminosalicylate

Aminosalicylic Acids

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

-0.0%

3Y

-0.4%

5Y

-0.2%

All

+57.5%

Generic Alternatives

Save up to 89%

2 alternatives • Same active ingredient

MESALAMINE ER 0.375 GRAM CAP

00093922489•Teva Pharmaceuticals USA Inc.

MESALAMINE ER 0.375 GRAM CAP

68682011320•Oceanside Pharmaceuticals

Related Drugs

Same classification

DIPENTUM 250 MG CAPSULE

00037686010•Viatris Specialty LLC

CANASA 1,000 MG SUPPOSITORY

58914050156•Allergan, Inc.

CANASA 1,000 MG SUPPOSITORY

58914050142•Allergan, Inc.